BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 27529389)

  • 1. Efficacy and limitations of treatment of ventricular fibrillation/ventricular tachycardia storm by subcutaneous implantable cardioverter defibrillator.
    Nagra B; Awan MU; Miriyala V; Kantharia BK
    Int J Cardiol; 2016 Nov; 222():978-979. PubMed ID: 27529389
    [No Abstract]   [Full Text] [Related]  

  • 2. "Train tracks" and "step ladders" on implantable cardioverter defibrillator interval plot in a patient with dual tachycardia: Putting the dots together.
    Saini A; Ellenbogen KA; Tan A; Kaszala K; Huizar JF
    Pacing Clin Electrophysiol; 2017 Nov; 40(11):1298-1301. PubMed ID: 28901551
    [No Abstract]   [Full Text] [Related]  

  • 3. Are electrophysiological studies needed before implantable cardioverter defibrillator surgery?
    Böcker D; Block M; Borggrefe M; Breithardt G
    Eur Heart J; 1997 Apr; 18(4):548-51. PubMed ID: 9129880
    [No Abstract]   [Full Text] [Related]  

  • 4. Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndrome.
    De Maria E; Cappelli S; Cappato R
    Heart Rhythm; 2013 Dec; 10(12):1807-9. PubMed ID: 23933298
    [No Abstract]   [Full Text] [Related]  

  • 5. Spurious redetection of sinus rhythm by an implantable cardioverter defibrillator during spontaneous ventricular fibrillation.
    Otto L; Mann DE; Kelly PA; Reiter MJ
    Pacing Clin Electrophysiol; 1999 Oct; 22(10):1550-2. PubMed ID: 10588160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive shock therapy of subcutaneous implantable cardioverter defibrillators in a patient with idiopathic ventricular fibrillation: What is the mechanism?
    Hasegawa K; Miyazaki S; Ishikawa E; Mukai M; Aoyama D; Nodera M; Kaseno K; Tada H
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2121-2124. PubMed ID: 31332856
    [No Abstract]   [Full Text] [Related]  

  • 7. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J; Schneider MA; Kuck KH
    Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inappropriate implantable cardioverter-defibrillator discharge associated with a new ventricular tachycardia treatment algorithm.
    Marine JE; Tomaselli GF; Leng CT
    Heart Rhythm; 2007 May; 4(5):655-7. PubMed ID: 17467637
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of ventricular fibrillations with different characteristics in the local electrocardiogram: large and small amplitude of activation, and its implication for implantable cardioverter defibrillator treatment.
    Chinushi M; Washizuka T; Kasai H; Ohhira K; Satoh M; Aizawa Y
    Jpn Circ J; 1999 Dec; 63(12):1007-10. PubMed ID: 10614851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of long-standing implantable cardioverter-defibrillator patients with and without appropriate therapy for ventricular arrhythmias: impact of a widening QRS.
    Dizon J; Chen K; Dizon S; Biviano A; Whang W; Ehlert F; Vazquez J; Nazif T; Garan H
    Europace; 2011 Jan; 13(1):77-81. PubMed ID: 21149513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrical storm and implanted defibrillators.
    Davis CP
    South Med J; 2007 May; 100(5):547-8. PubMed ID: 17534103
    [No Abstract]   [Full Text] [Related]  

  • 12. Augmented QRS notching and macroscopic T-wave alternans preceding polymorphic ventricular tachycardia in a patient with electrical storm.
    Minatoguchi S; Takasugi N; Kubota T; Ushikoshi H; Nishigaki K; Minatoguchi S
    Europace; 2017 Apr; 19(4):643. PubMed ID: 28339622
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
    Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
    Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
    Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC
    Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320
    [No Abstract]   [Full Text] [Related]  

  • 16. [How do we treat an electrical storm in implantable cardioverter defibrillator (ICD) appropriate patients?].
    Özin B
    Turk Kardiyol Dern Ars; 2014 Jun; 42(4):417. PubMed ID: 25112002
    [No Abstract]   [Full Text] [Related]  

  • 17. Coronary artery spasm as a cause of ST elevation and inappropriate implantable cardioverter defibrillator intervention.
    Mascioli G; Bontempi L; Racheli M; Cerini M; Curnis A; Cas LD
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1055-7. PubMed ID: 18163021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complications in transvenous and transvenous-subcutaneous implantable defibrillator systems].
    Podczeck A; Hief C; Veit F; Jakl G; Kaltenbrunner W; Nürnberg M; Frohner K; Steinbach K
    Z Kardiol; 1994 May; 83(5):366-72. PubMed ID: 8053246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant fascicular ventricular tachycardia degenerating into ventricular fibrillation in a patient with early repolarization syndrome].
    Kane A; Defaye P; Jacon P; Mbaye A; Machecourt J
    Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):292-5. PubMed ID: 21665187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.